GW2561 Crizotinib

Synonyms: Xalkori; PF-02341066; PF02341066; PF 02341066; (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine; 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine; 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine; (R)-3-[1-(2,6-Dichloro-3-fluorop henyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine

Structure for Crizotinib (877399-52-5)

CAS: 877399-52-5

MF: C₂₁H₂₂Cl₂FN₅O

MW: 450.34

Purity (HPLC): ≥ 98.0%

Availability: Lead time: 5 - 10 days

GW2561 Crizotinib

CAS: 877399-52-5 MF: C₂₁H₂₂Cl₂FN₅O MW: 450.34

Purity (HPLC): ≥ 98.0% | Availability: Lead time: 5 - 10 days | SDS | Specification

Code

Packaging

Stock ℹ

Dispatches

Size

No. Units

Price (USD)

Review Basket (0) & Checkout

Product Detail
Product Specification
Safety Information
Citations (0)

Glentham Code

GW2561

CAS RN

877399-52-5

MDL Number

MFCD12407409

Storage Temperature

+4°C

Shipping Temperature

Ambient

Harmonised Tariff Code

29333999

Physical Description

White to off-white powder

Identification (IR)

To conform to standard

Purity (HPLC)

≥ 98.0%

Specification Version

1.1

Pictograms

Signal word

Warning

Hazard statements

H317: May cause an allergic skin reaction.
H319: Causes serious eye irritation.
H341: Suspected of causing genetic defects.
H400: Very toxic to aquatic life.

Precautionary statements

P202: Do not handle until all safety precautions have been read and understood.
P273: Avoid release to the environment.
P280: Wear protective gloves/protective clothing/eye protection/face protection.
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P308 + P313: IF exposed or concerned: Get medical advice/attention.

UN Number

UN3077 - 9 - PG III

SDS Version

1.0

If you are publishing research using GW2561 please contact us to contribute to our list of citations.

Downloads (PDF)

SDS

Specification View

Technical Datasheet Request

Certificate of Analysis

Example COA

Packaging Description For GW2561-10MG

Description: 2ml glass vial with plastic stopper (+50ml plastic screw pot - 50S)

Material: glass vial with plastic push fit stopper

Dimensions: 0 x 0 x 0 (mm)

Nominal volume: 2 (ml)

UN certified: No

Weight: 2.552 g

If you would like any further details, please call us on +44 (0) 1225 667798 or send us an e-mail.

Stock Level Information

Our stock availability is calculated based on the quantity that we have in stock.

If a number of stock units is given in orange, we have enough material in smaller packs or in bulk to re-pack into these larger units.

This would not affect the dispatch date displayed.

For any questions or to check our stock, please call us on +44 (0) 1225 667798 or send us an e-mail.

Feedback

Settings

GW2561 Crizotinib

GW2561 Crizotinib

CAS: 877399-52-5 MF: C₂₁H₂₂Cl₂FN₅O MW: 450.34

Recently Viewed Products

Packaging Description For GW2561-10MG

Stock Level Information

About Us

Navigation

Contact Us

Email:

Password:

	Forgot your password?

Cookies

Feedback

Settings

GW2561 Crizotinib

GW2561 Crizotinib

CAS: 877399-52-5 MF: C21H22Cl2FN5O MW: 450.34

Recently Viewed Products

Packaging Description For GW2561-10MG

Stock Level Information

About Us

Navigation

Contact Us

CAS: 877399-52-5 MF: C₂₁H₂₂Cl₂FN₅O MW: 450.34